Pharma giant Bayer moves deeper into digital health with new business unit

Pharma giant Bayer, is establishing a precision health unit as part of its increased investment in consumer-facing digital health tools.

The company aims to develop products that empower individuals to take greater control of their personal health through digital solutions, enabling informed choices based on personal insights and innovative delivery methods, according to a press release.

The new precision health unit represents Bayer's progression in the field of digital health, and will add digital tools and services alongside the company's diagnostics and physical products.

Advancements in technology have facilitated the emergence of various digital products, including diagnostics, apps, and therapeutics, that assist consumers in predicting, preventing, and managing their health. Bayer recognises the opportunity to bridge the gap between monitoring, awareness, and diagnosis with digital health tools on one end and education, treatment, and prevention on the other.

The Bayer Precision Health group will identify consumer healthcare opportunities supported by digital technologies. The division will be embedded within the business and comprise leaders with diverse responsibilities and expertise.

Although Bayer did not specify the specific products or healthcare sectors it will focus on, it aims to address unmet needs in its core categories and develop evidence-based precision health products that offer comprehensive self-care solutions. Bayer intends to collaborate with startups and other digital health providers, as well as enhance its existing digital capabilities.

Click here to read the original news story.